This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
HCV Infection
and you are
between 18 and 79
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study will evaluate the pharmacokinetics, safety, and tolerability of GS-9857 in adults with severe renal impairment and matched healthy control adults.

Provided treatments

  • Drug: GS-9857
Tris trial is registered with FDA with number: NCT02402452. The sponsor of the trial is Gilead Sciences and it is looking for 20 volunteers for the current phase.
Official trial title:
A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-9857 in Subjects With Normal Renal Function and Severe Renal Impairment